Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.

All the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. The Journal is published monthly in English.

Manuscripts will be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/, link which is also accessible through the main web page of Archivos de Bronconeumologia.

Access to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. Furthermore, the Journal is also present in Twitter and Facebook. The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).

Authors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous Issue | Next Issue

Issue

Vol. 60. Issue 10.

Pages 607-672 (October 2024)

CO1

Arch Bronconeumol. 2024;60:CO1

Editorial Board

Arch Bronconeumol. 2024;60:i

Contents

Arch Bronconeumol. 2024;60:iii-iv

Editorials

How to Protect Radon Exposed Workers? Advocating for a Specific Health Surveillance Protocol

Lucía Martín-Gisbert, Montserrat García Gómez, Alberto Ruano Ravina

Arch Bronconeumol. 2024;60:607-8

Non-Tuberculous Mycobacterial Pulmonary Disease—Where are we Now?

Kartik Kumar, Michael R. Loebinger

Arch Bronconeumol. 2024;60:609-11

Original articles

Non-Pharmacological Interventions During SARS-CoV-2 Pandemic: Effects on Pediatric Viral Respiratory Infections

Georgina Armero, Carmina Guitart, Aleix Soler-Garcia, Maria Melé, Cristina Esteva, Pedro Brotons, Carmen Muñoz-Almagro, Iolanda Jordan, Cristian Launes

Arch Bronconeumol. 2024;60:612-8

Highlights

•
The SARS-CoV-2 pandemic provided an opportunity to assess the impact of non-pharmacological measures.
•
This assessment should encompass the effects of implementing and lifting these measures.
•
In this study, deseasonalized time-series analysis was used to evaluate these effects.
•
The rates of rhinovirus, RSV, HMPV, and influenza detections were influenced by decisions regarding these measures.
•
Specifically, mandatory face masks for the population aged 6 and older interfered with the circulation of these viruses.

Medium-Term Disability and Long-Term Functional Impairment Persistence in Survivors of Severe COVID-19 ARDS: Clinical and Physiological Insights

Raquel Casitas, Raúl Galera, María Torres-Vargas, Sara Garcia-Tovar, Enrique Alfaro, Elena Díaz-Garcia, Elisabet Martinez-Cerón, Miguel Garcia-Garcia, ... Francisco García-Río

Arch Bronconeumol. 2024;60:619-26

Effect of CPAP Treatment on Cardiovascular Outcomes

Jordi de Batlle, Esther Gracia-Lavedán, Joan Escarrabill, Anna García-Altés, Elisenda Martinez Carbonell, Mario Henríquez-Beltrán, Manuel Sánchez-de-la-Torre, Ferran Barbé

Arch Bronconeumol. 2024;60:627-33

Spirometric Transition of at Risk Individuals and Risks for Progression to Chronic Obstructive Pulmonary Disease in General Population

Yong Suk Jo, Chin Kook Rhee, Sang Hyuk Kim, Hyun Lee, Joon Young Choi

Arch Bronconeumol. 2024;60:634-42

Highlights

•
Chronic obstructive pulmonary disease (COPD) has been shown to be a progressive disease with various precursors, including pre-COPD and preserved ratio and impaired spirometry (PRISm). These states were identified as potentially lead to COPD, but their lung function trajectories and risks associated with their progression were not fully understood.
•
This study reveals distinct trends in longitudinal lung function trajectories in patients with pre-COPD and PRISm. It identifies these conditions as significant risk factors for future COPD development. However, in PRISm patients, the concurrent presence of cardiovascular disease (CVD) should be considered.
•
Our findings emphasize the importance of early detection and intervention in individuals with pre-COPD and PRISm.